Dusa Pharma (Dusa)

[surf1944]

2) DUSA Pharmaceuticals Inc. (DUSA)
Sector: Healthcare
Industry: Drug Manufacturers - Other
Market Cap: $132.63M
Beta: 0.80

DUSA Pharmaceuticals Inc. has a Current Ratio of 6.61, a Quick Ratio of 6.03, and a 5-Year Projected Earnings Per Share Growth Rate of 27.00%. The short interest was 5.76% as of 07/08/2012. DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea. The company's marketed products include Levulan Kerastick 20% Topical Solution with PDT, as well as the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. It also markets the BLU-U without Levulan PDT for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions.


http://seekingalpha.com/article/710571-5-high-growth-healthcare-stocks-fueled-by-large-cash-reserves?source=yahoo